About Lexicon Pharmaceuticals, Inc
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; LX9211, which is in Phase II clinical development for the treatment of neuropathic pain; and LX2761. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas. Address: 8800 Technology Forest Place, The Woodlands, TX, United States, 77381-1160
Lexicon Pharmaceuticals, Inc News and around…
Latest news about Lexicon Pharmaceuticals, Inc (LXRX) common stock and company :
Gainers Voyager Therapeutics (NASDAQ:VYGR) shares increased by 46.15% to $3.61 during Wednesday's pre-market ...
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes Bank of America Corp (NYSE: BAC). He met the CFO over the ...
During Tuesday's Mad Money "Lightning Round", one caller asked Jim Cramer about a company by the name of Lexicon Pharmaceuticals : "I like companies like this," he responded. Let's check out the chart of this biopharmaceutical company that is using gene science. In this daily bar chart of LXRX, below, we can see that prices made a rapid run-up in late 2020 and then declined from February to July/August.
In trading on Friday, shares of Lexicon Pharmaceuticals, Inc. (LXRX) crossed above their 200 day moving average of $5.10, changing hands as high as $5.31 per share..
Gainers Valneva (NASDAQ:VALN) stock rose 17.45% to $45.22 during Monday's pre-market session. The market value of ...
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss ...
Lexicon Pharmaceuticals Inc(NASDAQ: LXRX) haspresented additional analysesfrom SOLOIST and SCORED Phase 3 trials ...
Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same ...
Lexicon (LXRX) delivered earnings and revenue surprises of 18.75% and 680.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) were unchanged after the company reported Q2 results. Quarterly ...
Conference Call and Webcast at 8:00 am Eastern Time
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its ...
Lexicon (LXRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gainers Moderna (NASDAQ:MRNA) stock increased by 7.67% to $279.6 during Friday's pre-market session. The ...
In trading on Thursday, shares of Lexicon Pharmaceuticals, Inc. (LXRX) crossed below their 200 day moving average of $4.33, changing hands as low as $4.26 per share..
Investors in Lexicon Pharmaceuticals, Inc. (LXRX) saw new options become available this week, for the August 20th expiration..
Gainers IKONICS Corporation (NASDAQ: IKNX) shares surged 64.3% to close at $18.56 on Friday after the company reported a merger ...
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Lexicon Pharmaceuticals, Inc. (LXRX), where a total of 9,338 contracts have traded so far, representing approximately 933,800 underlying shares..
Investors in Lexicon Pharmaceuticals, Inc. (LXRX) saw new options become available this week, for the June 18th expiration..
Lexicon (LXRX) delivered earnings and revenue surprises of 11.76% and -99.20%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Lexicon Pharmaceuticals, Inc (LXRX) is a NASDAQ Common Stock listed in Biotechnology, Common Stock, Healthcare
